← Back to Patent Explorer
US3939259A Expired / Lapsed US ⏱️ 0.0 years remaining

Coating composition and therapeutic preparation incorporating same

Assignee: Individual
•
Filing: 1974-05-24
•
Granted: 1976-02-17
•
Expires: 1994-05-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A therapeutic preparation consisting of particles containing a therapeutically active material are coated with a disintegratable coating comprising zein and shellac. A first group of particles contains no coating or a coating subject to rapid disintegration upon ingestion to release an initial dose of therapeutic material and remaining groups of particles are coated with increasingly thicker coatings for delayed disintegration to release subsequent doses of therapeutic material. The coating composition may include disintegration modifiers so that thinner coatings of the zein-shellac coating material can be employed than would be required for zein shellac alone to obtain the delayed disintegration of the coating.

Inventors

  • 👤 Anthony Pescetti

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 01:34
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/5073; A61K9/5078

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 187 words
A therapeutic preparation comprising a pharmaceutical gelatin capsule containing a blend of three groups of particles containing a pharmaceutically active material, said first group containing a unit dose amount of said material for release thereof within a period of one hour after ingestion, a second group of said particles containing a unit dose amount of said material being provided with a coating comprising a major proportion of zein and shellac in a weight/weight ratio of between 1:7 and about 1:14 and minor proportions of ethyl cullulose, bees wax and a plasticizer, said coating having an effective thickness for disintegration and relase of said material in a period of about 4 hours after ingestion, and a third group of said particles containing a unit dose amount of said material being provided with a coating comprising a major proportion of zein and shellac in a weight/weight ratio of between about 1:7 and about 1:14 and minor proportions of ethyl cellulose, bees wax, polyvinylpyrrolidone and a plasticizer, said coating having an effective thickness for disintegration and relase of said material in about a period of about 8 hours after ingestion.
Claim 2
Dependent Claim 187 words
A therapeutic preparation comprising a pharmaceutical gelatin capsule containing a blend of three groups of particles containing a pharmaceutically active material, said first group containing a unit dose amount of said material for release thereof within a period of one hour after ingestion, a second group of said particles containing a unit dose amount of said material being provided with a coating comprising a major proportion of zein and shellac in a weight/weight ratio of between 1:7 and about 1:14 and minor proportions of ethyl cullulose, bees wax and a plasticizer, said coating having an effective thickness for disintegration and relase of said material in a period of about 4 hours after ingestion, and a third group of said particles containing a unit dose amount of said material being provided with a coating comprising a major proportion of zein and shellac in a weight/weight ratio of between about 1:7 and about 1:14 and minor proportions of ethyl cellulose, bees wax, polyvinylpyrrolidone and a plasticizer, said coating having an effective thickness for disintegration and relase of said material in about a period of about 8 hours after ingestion.
Claim 3
Dependent Claim 13 words
The therapeutic preparation of claim 1 wherein said pharmaceutically active material is digitoxin.

References Cited (Backward Citations)

US2953497A Cited
US2996431A Cited
US2928770A Cited
US3080294A Cited
US3115441A Cited
US3344029A Cited
US3365365A Cited
US3524756A Cited
US3576663A Cited
US3738952A Cited
US3741795A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-02-16 1979-08-18 1980-02-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-02-16 1983-08-18 1984-02-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-02-16 1987-08-18 1988-02-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag